TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Earnings
TEVA PHARMACEUTICAL INDUSTRIES LTD's most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Next earnings (estimated)
Around Jan 11, 2027
From past filing pattern
Get notified when TEVA reports →Last reported earnings
Nov 3, 2026
From the latest earnings 8-K
Revenue • FY2025
$17.26B
▲ 4.3%YoY
Diluted EPS • FY2025
$1.21
▲ 183.4%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from TEVA's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $17.26B | $1.41B | $8.94B | $1.21 | $1.15B | 12.5% | +4.3% |
| FY2024 | $16.54B | -$1.64B | $8.06B | -$1.45 | $749M | -1.8% | +4.4% |
| FY2023 | $15.85B | -$559M | $7.64B | -$0.50 | $842M | 2.7% | +6.2% |
| FY2022 | $14.93B | -$2.35B | $6.97B | -$2.12 | $1.04B | -14.1% | -6.0% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Nov 3, 2026 | 8-K (2.02) | 0001171843-26-007054EDGAR |
| Jul 29, 2026 | 8-K (2.02) | 0001171843-26-004974EDGAR |
| Apr 29, 2026 | 8-K (2.02) | 0001171843-26-002796EDGAR |
| Jan 28, 2026 | 8-K (2.02) | 0001171843-26-000462EDGAR |
| Jan 12, 2026 | 8-K (2.02) | 0001171843-26-000174EDGAR |
| Nov 5, 2025 | 8-K (2.02) | 0001171843-25-007000EDGAR |
| Jul 30, 2025 | 8-K (2.02) | 0001171843-25-004808EDGAR |
| May 7, 2025 | 8-K (2.02) | 0001171843-25-002849EDGAR |
Never miss a TEVA filing.
Get an email when TEVA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.